Functional Dyspepsia Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies – Astellas Pharma & Zeria Pharmaceuticals

DelveInsight Business Research LLP

DelveInsight’s “Functional Dyspepsia Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Functional Dyspepsia, historical and forecasted epidemiology as well as the Functional Dyspepsia market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Key Highlights Functional Dyspepsia  Market 

• Key Companies working in the Functional Dyspepsia market are Astellas Pharma & Zeria Pharmaceuticals and many others.

• Key Therapies in Functional Dyspepsia are taVNS 10, Itopride, and many others 

Functional Dyspepsia Overview

Functional dyspepsia (dis-PEP-see-uh) is a term for recurring symptoms of an upset stomach that have no obvious cause. Functional dyspepsia also is called nonulcer dyspepsia. Functional dyspepsia is common. It is a constant condition but symptoms don’t happen all the time. Symptoms resemble those of an ulcer. They include pain or discomfort in the upper abdomen, bloating, belching, and nausea. Dyspepsia symptoms are sporadic: They come and go without clear reasons, and it’s hard to tell if anything in particular makes them better or worse. While functional dyspepsia is chronic — ongoing over a long period of time — it may disappear for a while and then return for unknown reasons. To be diagnosed, you must have had symptoms within the last three months and persistently for at least six months. You’ll also have more than one of the following symptoms: Epigastric pain. This is a pain in the upper abdomen under the ribcage. This region called the epigastrium, is home to your stomach, small intestine, pancreas and liver, and Bloated stomach. Feelings of uncomfortable pressure or fullness in your belly, especially after eating.

Functional Dyspepsia Epidemiology Insights

• Large population-based studies revealed that the prevalence of FD ranges from 10% to 30% worldwide.

Click here to learn more about the Functional Dyspepsia Market Landscape

The Report Covers the Functional Dyspepsia  Epidemiology Segmented by:

• Functional Dyspepsia prevalent cases  

• Functional Dyspepsia incident cases 

• Functional Dyspepsia  treatment cases 

• Functional Dyspepsia diagnosed cases 

Functional Dyspepsia Market Outlook 

The Functional Dyspepsia market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Functional Dyspepsia market trends by analyzing the impact of current Functional Dyspepsia therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of the Functional Dyspepsia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Functional Dyspepsia market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Functional Dyspepsia market in 7MM is expected to witness a major change in the study period 2019-2032.

Key Companies Working in the Functional Dyspepsia Market

•  Astellas Pharma 

• Zeria Pharmaceuticals 

And many others.

Functional Dyspepsia Therapies Covered and Analyzed in the Report

•  taVNS 10

• Itopride

And many others 

Learn more about the Key Companies and Emerging Therapies in the Functional Dyspepsia  Market

 Table of Contents 

1.  Key Insights 

2.  Functional Dyspepsia Introduction 

3.  Executive Summary of Functional Dyspepsia             

4.  Disease Background and Overview

5.  Epidemiology and patient population

6.  Functional Dyspepsia Emerging Therapies

7.  Functional Dyspepsia Market Outlook

8.  Market Access and Reimbursement of Therapies

9.  Market Drivers 

10.  Market Barriers 

11.  Appendix

12.  Report Methodology

13.  DelveInsight Capabilities

14.  Disclaimer

Learn about the detailed offerings of the report @ Functional Dyspepsia Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services